QTTB — Q32 Bio Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1661998 ·
Last close
$15.68
Market Cap
$465.83M
52W High
$23.57
52W Low
$4.97
ADV30
1,894,240
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,722,000 | -7,609,000 | 63,675,000 | 50,751,000 | 17,362,000 |
| Dec 2025 | 53,737,000 | — | 45,879,000 | 57,730,000 | 61,776,000 | 48,297,000 | 19,762,000 |
| Sep 2025 | 0 | — | -7,577,000 | -7,389,000 | 57,784,000 | 49,039,000 | 76,232,000 |
| Jun 2025 | 0 | — | -9,171,000 | -9,489,000 | 66,117,000 | 54,832,000 | 78,352,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-33,543,000
Investing CF
$7,000,000
Financing CF
$-3,125,000
CapEx
$-60,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.74
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-204,993,000
Inventory
—
Receivables
$5,392,000
ST Investments
—
EBIT TTM
$30,921,000
Pretax Income TTM
$29,821,000
Interest Exp TTM
$1,100,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$53,737,000
EBITDA
$21,770,000
Free Cash Flow
$9,871,000
Enterprise Value
$226,736,816
Total Cash
$50,751,000
Total Debt
$13,646,000
Shares Out
29,708,814
Trailing EPS
$2.78
Book Value
$3.17
ROE
157.2%
ROA
18.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 53,737,000 | 16,902,000 | 29,821,000 | 61,776,000 | 19,762,000 | — | -33,543,000 |
| Dec 2024 | 0 | -66,102,000 | -47,733,000 | 92,332,000 | 86,657,000 | — | -67,715,000 |
| Dec 2023 | -6,651,000 | -48,255,000 | -53,743,000 | 47,057,000 | 229,978,000 | — | -18,677,000 |
| Dec 2022 | 6,651,000 | -39,225,000 | -42,809,000 | 61,774,000 | 192,486,000 | — | -10,957,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.42
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VREOF | Vireo Growth Inc. | $466.74M | $9.49 | — |
| AQST | Aquestive Therapeutics, Inc. | $463.60M | $3.69 | — |
| RZLT | Rezolute, Inc. | $454.50M | $4.72 | — |
| HELP | CYBIN INC. | $484.72M | $7.82 | — |
| SLN | Silence Therapeutics plc | $495.49M | $10.49 | — |
News headlines (Yahoo Finance, 1h cache)
Are You Looking for a Top Momentum Pick? Why Q32 Bio (QTTB) is a Great Choice
2026-07-20 16:00 · Yahoo
Wall Street Analysts See an 80.12% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
2026-07-15 13:55 · Yahoo
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants
2026-07-15 02:58 · Yahoo
Q32 Bio stock surges 83% on positive alopecia drug trial data
2026-07-14 13:04 · Yahoo
Q32 Bio (QTTB) After Positive Trial Data Is It A Buy Or Already Fairly Valued
2026-07-14 10:14 · Yahoo
Why Did AAPL, QTTB, CSX Stocks Surge To 52-Week Highs Today?
2026-07-14 02:14 · Yahoo
Why Q32 Bio Stock Skyrocketed Today
2026-07-14 01:58 · Yahoo
QTTB Stock Clocks Best Day In A Year Following Positive Alopecia Data — Analyst Sees Further 200% Upside
2026-07-13 21:00 · Yahoo
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
2026-07-13 20:01 · Yahoo
Top Midday Gainers
2026-07-13 17:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.